Marker Therapeutics
MRKR
MRKR
8 hedge funds and large institutions have $904K invested in Marker Therapeutics in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NRS
Neville Rodie & Shaw
New York
|
+$479K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.5K |
| 3 |
BlackRock
New York
|
+$2.29K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.14K |
Top Sellers
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$8.62K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NRS
1
Neville Rodie & Shaw
New York
| $479K | +$479K | +12,210 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $356K | +$33.5K | +850 | +10% |
|
|
3
BlackRock
New York
| $57K | +$2.29K | +58 | +4% |
|
|
4
UBS Group
Zurich,
Switzerland
| $9K | +$1.14K | +30 | +15% |
|
|
NSIM
5
North Star Investment Management
Chicago,
Illinois
| $2K | -$8.62K | -181 | -81% |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|